CD274 and cancer: Therefore, to better study the role of MAPK on PD-L1 expression regulation, we treated two selected cancer cell lines with the MEK-I, selumetinib: one with highest level of PD-L1, H460, and the other with intermediate levels of PD-L1, H1299.